U.S. Water Utilities Stock News

NYSE:LNN
NYSE:LNNMachinery

Lindsay Names New CAO As Investors Weigh Governance And Return Signals

Lindsay Corporation (NYSE:LNN) has appointed Brett R. Coburn as Chief Accounting Officer. The leadership change affects responsibility for the company’s accounting, financial reporting, and internal controls. Investors may watch this appointment for any impact on Lindsay’s governance and financial oversight. Lindsay, trading at $122.99, has seen mixed share performance in recent years, with a 1.5% year-to-date return and a 1-year return of an 8% decline. Over 3 and 5 years, returns of a...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Arcellx (ACLX) Is Up 8.1% After FDA Eases Myeloma Trial Endpoints With New MRD Guidance

The U.S. FDA recently issued draft guidance allowing minimal residual disease and complete response to be used as endpoints for accelerated approval in multiple myeloma therapies, a framework that directly affects Arcellx’s anito-cel program with Kite Pharma. This regulatory shift may meaningfully influence how Arcellx designs and interprets its clinical trials, potentially reshaping timelines and evidence thresholds for its multiple myeloma candidate. We’ll now examine how the FDA’s focus...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

US High Growth Tech Stocks To Watch In January 2026

As the United States market experiences a rebound following recent volatility, with major indices like the Dow Jones and S&P 500 showing significant gains after addressing geopolitical tensions, investors are keeping a close eye on high-growth sectors. In this dynamic environment, identifying tech stocks with strong fundamentals and innovative potential can be crucial for navigating the opportunities presented by such market fluctuations.
NYSE:NIC
NYSE:NICBanks

3 Stocks That May Be Undervalued By Up To 40.9% Based On Intrinsic Value Estimates

Amid recent volatility in the U.S. markets, with major indices like the Dow Jones and S&P 500 experiencing significant fluctuations due to geopolitical tensions and economic policy shifts, investors are keenly observing opportunities that may arise from these movements. In such an environment, identifying stocks that are potentially undervalued based on intrinsic value estimates can offer a strategic advantage, as they might provide growth potential when market conditions stabilize.
NasdaqGM:CNTB
NasdaqGM:CNTBBiotechs

3 Promising Penny Stocks With Market Caps Up To $400M

Major stock indexes saw a significant rebound recently, with the Dow Jones adding 450 points after President Trump ruled out the use of force in Greenland. Amidst this backdrop of market volatility and geopolitical tensions, investors are exploring opportunities beyond traditional stocks. Penny stocks, often representing smaller or newer companies, continue to attract attention for their potential value and growth prospects. In this article, we explore three penny stocks that showcase...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

Should UFPI’s Sliding EPS and Returns on Capital Require Action From UFP Industries (UFPI) Investors?

UFP Industries recently reported that unit sales have fallen over the past two years, with earnings per share dropping faster than revenue and returns on capital slipping, pointing to past profit pools becoming harder to sustain. This combination of weaker volumes, compressed earnings, and declining capital efficiency raises fresh questions about how durable the company’s profit engine may be. Next, we’ll examine how the ongoing slide in earnings per share shapes UFP Industries’ investment...
NYSE:MTN
NYSE:MTNHospitality

How Investors May Respond To Vail Resorts (MTN) Near‑Record Low Snowpack And Weaker Skier Visits

Vail Resorts recently reported that Vail Mountain’s snowpack hit its lowest level in 47 years, with snowfall in the Rockies down sharply versus long‑term averages, limiting terrain openings and reducing skier visits earlier this season. Beyond immediate operational pressures, the snow drought has intensified concerns about regional water supplies and highlighted how weather variability can affect both resort performance and local communities. We’ll now examine how these historically poor...
NYSE:J
NYSE:JProfessional Services

Jacobs Solutions (J) Valuation Check After Securing Key Sizewell C Nuclear Project Role

Jacobs Solutions (J) has been selected by Sizewell C for a five year Professional Services Framework on a new nuclear power station in Suffolk, England, placing the company at the center of a major low carbon energy project. See our latest analysis for Jacobs Solutions. Despite landing several sizeable contracts across nuclear, water infrastructure and high performance computing in January, Jacobs’ recent share price return has been mixed, with a 1 day decline of 2.65%, a 90 day share price...
NYSE:DAN
NYSE:DANAuto Components

Assessing Dana (DAN) Valuation After High End 2025 Guidance And Profitability Focus

What triggered the latest interest in Dana (DAN)? Dana (DAN) is back on investors’ radar after the company issued 2025 sales guidance of US$7.30b to US$7.70b, alongside preliminary 2025 results that landed at the high end of its own expectations. See our latest analysis for Dana. That guidance and the focus on profitability and balance sheet repair arrive after a strong run in the stock, with a 90 day share price return of 38.54% and a 1 year total shareholder return of 104.87%. This comes...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Pharmaceuticals (CRVS) Is Up 229.4% After Strong Soquelitinib Data In Tough Dermatitis Patients

Corvus Pharmaceuticals recently reported positive results from cohort 4 of its randomized, blinded, placebo-controlled Phase 1 trial of oral soquelitinib in moderate to severe atopic dermatitis, and confirmed plans to start a Phase 2 study in the first quarter of 2026. The cohort 4 data are particularly interesting because they show clinical activity in patients who had previously failed systemic treatments, including dupilumab and JAK inhibitors, while maintaining a favorable safety profile...
NYSE:PKG
NYSE:PKGPackaging

How PKG’s Shift Toward Cost Efficiency and Shareholder Returns Will Impact Packaging Corporation of America (PKG) Investors

In recent months, Packaging Corporation of America has benefited from growing optimism about a recovery in the packaging cycle, supported by disciplined containerboard pricing and management’s focus on high-return mill investments. What stands out is the company’s decision to emphasize cost efficiency and cash returns to shareholders instead of pursuing large acquisitions, signaling a measured approach to capital allocation. Next, we’ll examine how this emphasis on disciplined pricing...
NYSE:ETR
NYSE:ETRElectric Utilities

A Look At Entergy (ETR) Valuation As Analysts Turn More Positive On EPS Growth Prospects

Entergy (ETR) is back in focus after several Wall Street firms reiterated or upgraded their views, pointing to expectations for sustained EPS growth supported by industrial and data center demand and constructive regulation. See our latest analysis for Entergy. At a share price of US$94.75, Entergy’s recent 30 day share price return of 3.55% contrasts with a softer 90 day share price return of a 1.30% decline. A 1 year total shareholder return of 16.51% sits alongside very strong 3 and 5 year...
NYSE:SUI
NYSE:SUIResidential REITs

Assessing Sun Communities (SUI) Valuation After Recent Flat Multi Year Share Performance

What Sun Communities’ recent performance might be telling investors Sun Communities (SUI) has drawn attention after a recent move that left its shares around $125.99, with total return over the past year at about 5%, and roughly flat performance over the past 3 years. See our latest analysis for Sun Communities. The recent 1 day share price decline of about 3.3% comes after a 30 day share price return of 2.7% and a 1 year total shareholder return of roughly 5%, suggesting only modest momentum...
NYSE:SCI
NYSE:SCIConsumer Services

A Look At Service Corporation International (SCI) Valuation After Earnings Beat And Fresh Analyst Coverage

Service Corporation International (SCI) has been in focus after its latest quarter showed 4.4% year on year revenue growth, topping analyst expectations by 1.5%, while recent positive Wall Street coverage has added another layer of investor attention. See our latest analysis for Service Corporation International. The share price, which closed at $82.35, has had a 5.3% 30 day share price return and a 6.7% year to date share price return. The 5 year total shareholder return of 66.1% points to...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

The Bull Case For Disc Medicine (IRON) Could Change Following FDA Review Delay And New HR Chief Appointment

Disc Medicine recently faced a two-week postponement of the U.S. FDA’s review of its rare disease candidate bitopertin, as regulators raised questions about efficacy endpoints, data integrity, and potential abuse risk. At the same time, the company appointed industry veteran Lisa Amaya Price as Chief Human Resources Officer, signaling an effort to strengthen its organizational backbone as it prepares for possible commercialization. Next, we’ll examine how the FDA’s temporary review delay for...
OTCPK:OZSC.D
OTCPK:OZSC.DElectrical

A Look At Ozop Energy Solutions (OTCPK:OZSC) Valuation After The 1 For 5,000 Reverse Stock Split

Reverse split reshapes Ozop Energy Solutions share structure Ozop Energy Solutions (OZSC) is carrying out a 1 for 5,000 reverse stock split effective January 21, 2026. This move sharply consolidates its share count and changes the trading price per share. This type of corporate action does not alter the company’s reported revenue of US$0.32 million or its loss of US$6.95 million, but it can influence liquidity, trading behavior, and how different investors view the stock. See our latest...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Assessing Workday (WDAY) After A 27% Slide And Conflicting Valuation Signals

Some investors may be wondering whether Workday is starting to look interesting at its current price, or whether the shares still carry a premium that is hard to justify. After closing at US$182.99, the stock has seen a 16.3% decline over the last 30 days and a 27.0% decline over the last year. These moves may have changed how some investors think about its growth potential and risk. Recent coverage has focused on Workday's position in enterprise software and its ongoing push to win and...
NYSE:OHI
NYSE:OHIHealth Care REITs

Omega Healthcare Investors Breakout Highlights Undervalued Healthcare REIT Opportunity

Omega Healthcare Investors (NYSE:OHI) is showing a strong technical breakout pattern, pointing to renewed investor interest in the healthcare REIT space. The breakout aligns with a confirmed uptrend and a solid technical setup that traders may use as a rule-based entry signal. With shares last closing at $45.04, the move is drawing fresh attention from investors watching healthcare focused real estate names. For context, Omega Healthcare Investors has delivered a 28.1% return over the past...
NYSE:AOS
NYSE:AOSBuilding

How Dividend Payout and Leonard Valve Deal Amid China Headwinds Will Impact A. O. Smith (AOS) Investors

A. O. Smith Corporation recently declared a regular quarterly cash dividend of US$0.36 per share, payable on February 17, 2026, to shareholders of record as of January 30, 2026, while also pursuing a US$470 million acquisition of Leonard Valve. This combination of maintaining its dividend and expanding through acquisition comes as the company narrows its outlook due to ongoing pressures in the Chinese market. We’ll now examine how the maintained dividend amid Chinese market headwinds shapes...
NYSE:ABT
NYSE:ABTMedical Equipment

Is Abbott Laboratories (ABT) Pricing Reflect Its Medical Device And Diagnostics Momentum?

If you are wondering whether Abbott Laboratories at around US$121 a share is offering fair value or a potential mispricing, you are in the right place. The stock is modestly positive over 1 year with a 5.7% return, but has seen shorter term pullbacks with a 2.5% decline over 7 days and a 3.4% decline over 30 days, while the 3 and 5 year figures sit at 14.2% and 15.7% respectively. Recent headlines around Abbott Laboratories have focused on its position in medical devices and diagnostics, as...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Roku Bets On Shoppable TV And AI As Valuation Signals Upside Potential

Roku and Pinterest have launched a new shoppable TV series on Roku, letting viewers buy products directly from what they see on screen. The rollout ties into Roku’s expansion of The Roku Channel and new AI powered tools such as conversational weather updates and real time content suggestions. These features are gaining traction with younger audiences and aim to deepen engagement on Roku’s platform. Roku, traded as NasdaqGS:ROKU, is leaning into interactive streaming at a time when its...
NYSE:OBK
NYSE:OBKBanks

Is Origin Bancorp (OBK) Pricing Its Recent Share Gains Fairly?

If you are wondering whether Origin Bancorp's current share price reflects solid value or hidden risk, it helps to start by lining up the recent performance with what you are actually paying for the business. The stock last closed at US$39.70, with returns of 1.1% over 7 days, 2.1% over 30 days, 5.5% year to date, 13.1% over 1 year, 8.7% over 3 years, and 47.1% over 5 years. This gives useful context before comparing the price to fundamentals. Recent coverage has focused on Origin Bancorp's...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Is Zoom Communications (ZM) Pricing Reflect Future Growth After Recent Share Price Weakness

If you are wondering whether Zoom Communications at around US$81 per share is still a quality name or already priced for perfection, its current valuation story is worth a closer look. The stock has recently seen a 2.2% decline over the past week, a 9.5% decline over the past month, a 2.4% decline year to date and a 3.5% gain over the past year, while its 3 year and 5 year returns stand at 17.1% and a 78.3% decline respectively. Recent news coverage has focused on how Zoom Communications...
NYSE:MRSH
NYSE:MRSHInsurance

Marsh Legal Standoff Over Howden Raids Tests Risk And Resilience

Marsh & McLennan Companies (NYSE:MRSH) has rejected settlement talks linked to alleged staff raids by rival Howden. The company is reported to view the Howden raids as the tip of the iceberg, pointing to wider competitive and legal tensions. The dispute highlights potential undisclosed legal exposure and operational risks that could be relevant for investors and clients. Marsh & McLennan is a major player in insurance broking, risk advisory and related consulting, so any legal friction tied...